Allergy: Clinical Trials

265 trials for Allergy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

180 completed, 34 unknown, 18 terminated, 16 recruiting. 77 Not applicable, 35 Phase 3, 29 Phase 2, 26 Phase 1, 14 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable77Completed 52, Unknown 13, Terminated 7, Recruiting 3, Not yet recruiting 2
Phase 335Completed 30, Recruiting 2, Unknown 2, Active not recruiting 1
Phase 229Completed 19, Terminated 5, Unknown 2, Enrolling by invitation 1, Recruiting 1, Withdrawn 1
Phase 126Completed 21, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Terminated 1
Phase 414Completed 7, Unknown 3, Recruiting 2, Terminated 2
Early Phase 13Completed 2, Recruiting 1

Follow Allergy: new trials by email Literature Review of Allergy trials Research Report on Allergy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Allergy, Asthma, and Atopic Eczema in Finland
No intervention, No Intervention: Observational Cohort - Asthma, Asthma in Children
Not yet recruitingTampere University12000002026-12-012026-10-15
Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG
DBFC with 150g of Alpha-gal Knock Out (KO) pork, DBFC with 150g of Wild Type (WT) pork - Alpha-Gal Syndrome, Allergy
Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)1602026-09-212026-10-08
LOGOGRAM: Validation of Allergy Care Flowcharts in Primary Care: Experience From Occitanie
Implementation of an innovative tool based around AI-automated decision trees on an application - Allergy
Not applicableNot yet recruitingUniversity Hospital, Montpellier6002026-09-012026-06-05
Study of Oral Food Challenge Biomarkers (SAFER)
Oral Food Challenge (OFC): Peanut Protein - Allergy
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)5002026-08-202026-10-23
Primary Allergy and Its Impact on the Occurrence of Respiratory Distress in Infants at 12 Months of Age
questionnaire - Allergy, Respiratory Distress
Not applicableRecruitingCentre Hospitalier Universitaire, Amiens5082026-07-012026-09-22
Direct Oral Challenges in Private Practice Setting to Delabeling Children With Beta-lactam Allergy
Allergy
RecruitingAssistance Publique - Hôpitaux de Paris2002026-06-012026-05-06
LYmph Node eXamination in Cat Allergen Immunotherapy
Intradermal cat allergen challenge - Allergy
Early Phase 1RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)162026-04-102026-05-01
Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.
skin prick test - Necrotizing Enterocolitis, Allergy
Not applicableNot yet recruitingSaglik Bilimleri Universitesi1302026-04-012026-05-01
Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing
Standardized questionnaires, Lung function tests, Prick tests - Allergy
Not applicableRecruitingUniversity Hospital, Montpellier1002026-02-042026-02-11
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Jack Jumper Ant Venom Immunotherapy - Allergy, Immunotherapy
Phase 4RecruitingMurdoch Childrens Research Institute1002025-11-252026-10-02
Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators
AllerTest-10 Multi-Head Skin Test Device, Skintestor OMNI Multi-Head Skin Test Device, Multi-Test II Multi-Head Skin Test Device - Allergy, Hypersensitivity, Immediate
Not applicableCompletedQHSLab, Inc.302025-11-122026-02-12
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
Skin Testing - Allergy
Phase 4CompletedMayo Clinic212025-11-052026-04-01
Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis
FMXIN002 single dose, Epinephrine autoinjector single dose, FMXIN002 single dose + NAC - Anaphylaxis, Allergy
Phase 1 / Phase 2Enrolling by invitationNasus Pharma502025-11-032025-11-14
Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial
Enhanced Education Package - Allergy
Not applicableTerminatedMurdoch Childrens Research Institute182025-08-222026-02-20
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
DBV712 250 mcg, Placebo - Allergy, Peanut Allergy
Phase 3Active not recruitingDBV Technologies4802025-06-242026-07-22
Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg
cetirizine HCl Gummy, Zyrtec tablet 10mg - Allergy
Phase 1UnknownSeattle Gummy Company302025-05-012024-06-13
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
blood sample - Immunology, Allergy
RecruitingInstitut National de la Santé Et de la Recherche Médicale, France5002025-04-092026-09-18
Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.
Allergy
RecruitingProbelte Pharma S.L.U.272025-02-012025-12-30
Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
Performing lung function tests (spirometry and fraction of exhaled nitric oxide (FeNO)), Filling of standardized questionnaires, Using an App on a device - Asthma in Children, Allergy
Active not recruitingUniversity Hospital, Montpellier5002025-01-302025-12-15

Showing 20 of 265. Sign in to see all of them.

Narrower conditions

Hypersensitivity (265)  ·  Asthma (58)  ·  Rhinitis, Allergic (19)  ·  Food Hypersensitivity (13)  ·  Rhinitis (12)  ·  Eczema (10)  ·  Infections (9)  ·  Dermatitis, Atopic (8)  ·  Respiratory Tract Infections (8)  ·  Anxiety Disorders (6)  ·  Pain (6)  ·  Rhinitis, Allergic, Seasonal (6)  ·  Anaphylaxis (5)  ·  Conjunctivitis (5)  ·  Hypersensitivity, Immediate (5)

Broader conditions

Immune System Diseases (264)  ·  Hypersensitivity, Immediate (102)  ·  Respiratory Tract Diseases (95)  ·  Respiratory Hypersensitivity (75)  ·  Lung Diseases (61)  ·  Bronchial Diseases (58)  ·  Lung Diseases, Obstructive (57)  ·  Otorhinolaryngologic Diseases (38)  ·  Pathological Conditions, Signs and Symptoms (38)  ·  Nose Diseases (35)  ·  Skin and Connective Tissue Diseases (28)  ·  Signs and Symptoms (26)  ·  Skin Diseases (25)  ·  Infections (23)  ·  Rhinitis (23)

Interventions

Blood Specimen Collection (8)  ·  Omalizumab (6)  ·  Patch Tests (6)  ·  Sublingual Immunotherapy (5)  ·  Fluticasone (4)  ·  Cetirizine (3)  ·  Fatty Acids, Omega-3 (3)  ·  Loratadine (3)  ·  Mometasone Furoate (3)  ·  Prednisone (3)  ·  Sodium Chloride (3)  ·  Surveys and Questionnaires (3)  ·  Albuterol (2)  ·  Basophil Degranulation Test (2)  ·  Budesonide (2)

Sponsors

ALK-Abelló A/S (21)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (10)  ·  Stallergenes Greer (8)  ·  Federico II University (5)  ·  Medical University of Vienna (5)  ·  University Hospital, Montpellier (5)  ·  Allergopharma GmbH & Co. KG (4)  ·  Mayo Clinic (4)  ·  National Institute of Environmental Health Sciences (NIEHS) (4)  ·  Société des Produits Nestlé (SPN) (4)  ·  University of North Carolina, Chapel Hill (4)  ·  Alyatec (3)  ·  Carmel Medical Center (3)  ·  Central Hospital, Nancy, France (3)  ·  Circassia Limited (3)

Countries

United States (67)  ·  France (31)  ·  Germany (23)  ·  Denmark (16)  ·  United Kingdom (14)  ·  Canada (11)  ·  Italy (10)  ·  Spain (9)  ·  Austria (8)  ·  Turkey (Türkiye) (7)  ·  Netherlands (6)  ·  Switzerland (6)  ·  Australia (5)  ·  Belgium (5)  ·  Israel (5)

Top investigators

Alexei Gonzalez Estrada, MD (4)  ·  Kim Simonsen, MD (4)  ·  Haim Bibi, MD (3)  ·  Jacques Hebert, MD (3)  ·  Allan Linneberg, MD, PhD (2)  ·  Bo Chawes, PhD (2)  ·  Christina E West, MD, PhD (2)  ·  Darryl C Zeldin, M.D. (2)  ·  David Skoner, MD (2)  ·  Robert G Townley, MD (2)

Results publications

PMID 19769849, PMID 24836393, PMID 25685162, PMID 39740942, PMID 10586890, PMID 10856158, PMID 11136958, PMID 11237932, PMID 12019607, PMID 12442909, PMID 12576509, PMID 12714091, PMID 12752591, PMID 14616103, PMID 14616131, PMID 14619332, PMID 14726444, PMID 15035692, PMID 15481762, PMID 15699220, PMID 15946416, PMID 16030165, PMID 16083793, PMID 16155260, PMID 16387596, PMID 16552404, PMID 16890769, PMID 17156490, PMID 17307705, PMID 17620075, PMID 17620076, PMID 17631952, PMID 17651142, PMID 17845592, PMID 17935764, PMID 18086218, PMID 18155284, PMID 18310163, PMID 18331416, PMID 18394132, PMID 18431959, PMID 18925878, PMID 18951005, PMID 19046761, PMID 19119701, PMID 19130937, PMID 19135238, PMID 19136964, PMID 19159447, PMID 19243364

NIH funding

P01ES018176 (2), 1DP2HG012480-01 (1), 2009 (1), 2015 (1), 2023 (1), 5UH3OD023282 (1), P01AT002620 (1), P01HL070831 (1), R01AI165866 (1), R01AI202514 (1), R01HL109293 (1), R01HL122424 (1), U24AI152177 (1)